Effect of dehydroepiandrosterone administration in patients with poor ovarian response according to the Bologna criteria.
about
Efficacy and Safety of Pergoveris in Assisted Reproductive Technology--ESPART: rationale and design of a randomised controlled trial in poor ovarian responders undergoing IVF/ICSI treatmentDehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis.Diminished ovarian reserve in the United States assisted reproductive technology population: diagnostic trends among 181,536 cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System.Novel dehydroepiandrosterone troche supplementation improves the serum androgen profile of women undergoing in vitro fertilizationDehydroepiandrosterone (DHEA) supplementation and IVF outcome in poor responders.The use of coenzyme Q10 and DHEA during IUI and IVF cycles in patients with decreased ovarian reserve.Protection of cumulus cells following dehydroepiandrosterone supplementation.DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor Prognosis.Efficacy and safety of Ding-Kun-Dan for female infertility patients with predicted poor ovarian response undergoing in vitro fertilization/intracytoplasmic sperm injection: study protocol for a randomized controlled trial.DHEA use to improve likelihood of IVF/ICSI success in patients with diminished ovarian reserve: A systematic review and meta-analysisDehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort studyDefining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why
P2860
Q35844053-6CAAA032-FCFD-470D-B704-C560B2E6DEC7Q35994080-08BE022D-4201-4DF1-9F3A-3B08AD5CE686Q36030666-DF44B146-59F2-41D2-9542-CDE23DA36A4CQ36165407-2681951B-1F36-465F-A938-77724C2BA26AQ39031773-DB4A041B-B3DC-4605-9F87-6E2ADE79613BQ40038074-30E73D46-8544-4B41-A2FD-37E4609B6B95Q48040191-4FAE6BC6-C030-403D-9541-CAB6F546F4D2Q49832425-B028C244-95AB-497E-BD48-51598AFA289BQ49843249-27052434-838D-4246-9D65-440C41BB71E0Q58694257-388FF22A-ED8E-4C0B-AF42-7C957A8BC6B9Q58733372-7A8A208D-9AF3-477B-9093-3E796F3475A1Q58769667-F3E86C55-A969-4EC8-BDD2-ECF2B307FA9A
P2860
Effect of dehydroepiandrosterone administration in patients with poor ovarian response according to the Bologna criteria.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Effect of dehydroepiandrostero ...... rding to the Bologna criteria.
@ast
Effect of dehydroepiandrostero ...... rding to the Bologna criteria.
@en
type
label
Effect of dehydroepiandrostero ...... rding to the Bologna criteria.
@ast
Effect of dehydroepiandrostero ...... rding to the Bologna criteria.
@en
prefLabel
Effect of dehydroepiandrostero ...... rding to the Bologna criteria.
@ast
Effect of dehydroepiandrostero ...... rding to the Bologna criteria.
@en
P2093
P2860
P1433
P1476
Effect of dehydroepiandrostero ...... rding to the Bologna criteria.
@en
P2093
Guijin Zhu
Hanwang Zhang
P2860
P304
P356
10.1371/JOURNAL.PONE.0099858
P407
P577
2014-06-16T00:00:00Z